Stocks RGR Financial statements
Financial statementsSTURM RUGER & CO INC financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STURM RUGER & CO INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 664 | 522 | 496 | 411 | 569 | 731 | 596 | 544 | 536 | 546 |
| Cost of revenue | 445 | 368 | 361 | 311 | 377 | 451 | 416 | 410 | 421 | 465 |
| Gross profit | 220 | 154 | 134 | 99.5 | 191 | 280 | 180 | 134 | 114 | 81.2 |
| Research and development | 8.7 | 9.8 | 8.5 | 8.2 | 8 | 11.7 | 9.6 | 9.8 | 8.2 | 8.4 |
| General and administrative | 29 | 28.4 | 32.2 | 30.3 | 39 | 43.3 | 40.6 | 42.8 | 44 | 54.2 |
| Operating expenses | 85.1 | 77.7 | 67.3 | 60.2 | 72.3 | 76.4 | 76.6 | 81.5 | 82.8 | 93.5 |
| Operating income | 134 | 76.3 | 67 | 39.4 | 119 | 203 | 103 | 52.1 | 31.7 | -12.3 |
| Interest expense | 0.19 | 0.15 | 0.33 | 0.19 | 0.19 | 0.16 | 0.26 | 0.21 | 0.1 | 0.09 |
| Interest income | 0.01 | 0.03 | 0.21 | 2.59 | 1.13 | 0.05 | 2.55 | 5.47 | 4.89 | 3.26 |
| Other non-operating income | 1.51 | 1.3 | 1.71 | 3.65 | 1.83 | 3.46 | 4.82 | 6.74 | 6.12 | 5.14 |
| Pre-tax income | 136 | 77.6 | 68.7 | 43 | 121 | 207 | 108 | 58.8 | 37.8 | -7.16 |
| Income tax | 48.4 | 25.5 | 17.8 | 10.7 | 30.6 | 50.7 | 19.9 | 10.6 | 7.21 | -2.77 |
| Net income | 87.5 | 52.1 | 50.9 | 32.3 | 90.4 | 156 | 88.3 | 48.2 | 30.6 | -4.39 |
| EBITDA | 170 | 111 | 99 | 68.7 | 147 | 229 | 129 | 74.5 | 53.7 | 10.6 |
| EPS, basic | 4.62 | 2.94 | 2.92 | 1.85 | 5.17 | 8.87 | 5.00 | 2.73 | 1.79 | -0.27 |
| EPS, diluted | 4.59 | 2.91 | 2.88 | 1.82 | 5.09 | 8.78 | 4.96 | 2.71 | 1.77 | -0.27 |
| Shares, basic (weighted) | 18.9 | 17.7 | 17.5 | 17.5 | 17.5 | 17.6 | 17.6 | 17.7 | 17.1 | 16.2 |
| Shares, diluted (weighted) | 19 | 17.9 | 17.7 | 17.8 | 17.8 | 17.8 | 17.8 | 17.8 | 17.3 | 16.2 |
| Dividend per share | 1.73 | 1.36 | 1.10 | 0.82 | 6.51 | 3.36 | 2.42 | 6.27 | 0.69 | 0.62 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 87.1 | 63.5 | 38.5 | 35.4 | 20.1 | 21 | 65.2 | 15.2 | 10 | 18.5 |
| Short-term investments | 114 | 129 | 121 | 200 | 159 | 102 | 95.5 | 74.1 | ||
| Receivables | 69.4 | 60.1 | 45 | 52.6 | 57.9 | 57 | 65.4 | 59.9 | 67.1 | 64.5 |
| Inventory | 54.5 | 39.7 | 31.4 | 28.3 | 29.1 | 43.9 | 65 | 79.8 | 76.5 | 42.9 |
| Other current assets | 3.66 | 3.5 | 2.92 | 3.47 | 6.27 | 6.83 | 7.09 | 14.1 | 9.25 | 11.7 |
| Total current assets | 215 | 167 | 232 | 249 | 234 | 329 | 362 | 271 | 258 | 212 |
| Property, plant and equipment | 104 | 104 | 82.7 | 73.9 | 70.7 | 73.6 | 76.9 | 71.5 | 71.2 | 80.1 |
| Lease right-of-use assets | 2.61 | 2.12 | ||||||||
| Goodwill | 0.21 | 0.83 | 3.26 | 3.26 | 3.26 | 3.26 | 3.65 | |||
| Other non-current assets | 27.5 | 13.7 | 17.7 | 20.3 | 41.6 | 39.4 | 40 | 43.9 | 37.7 | 30.6 |
| Total assets | 347 | 284 | 336 | 349 | 348 | 442 | 485 | 399 | 384 | 342 |
| Accounts payable | 17 | 8.76 | 11.7 | 8.34 | 12.8 | 12.2 | 13.3 | 11.1 | 13.2 | 10 |
| Accrued liabilities | 17.2 | 4 | 20.7 | |||||||
| Deferred revenue | 7.48 | 9.62 | 0.08 | 1.03 | 0.15 | |||||
| Total current liabilities | 80.9 | 52.7 | 71.2 | 61.2 | 81.8 | 77.1 | 163 | 63.2 | 60.8 | 54.7 |
| Lease liabilities | 2.18 | 1.72 | 1.48 | 3.04 | 2.17 | 1.75 | 1.16 | |||
| Total liabilities | 81 | 54.2 | 71.3 | 63.5 | 83.6 | 78.7 | 168 | 67.1 | 64.5 | 58.2 |
| Paid-in capital | 27.2 | 28.3 | 33.3 | 38.7 | 43.5 | 46.8 | 45.1 | 46.8 | 50.5 | 55.4 |
| Retained earnings | 293 | 321 | 350 | 368 | 343 | 438 | 393 | 418 | 437 | 422 |
| Treasury stock | -78.7 | -144 | -144 | -146 | -146 | -146 | -146 | -158 | -192 | -218 |
| Shareholders' equity | 266 | 230 | 264 | 285 | 265 | 364 | 317 | 332 | 320 | 284 |
| Total equity | 266 | 230 | 264 | 285 | 265 | 364 | 317 | 332 | 320 | 284 |
| Total liabilities and equity | 347 | 284 | 336 | 349 | 348 | 442 | 485 | 399 | 384 | 342 |
| Shares outstanding | 17.7 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 87.5 | 52.1 | 50.9 | 32.3 | 90.4 | 156 | 88.3 | 48.2 | 30.6 | -4.39 |
| Depreciation and amortization | 35.4 | 34.3 | 32 | 29.3 | 27.6 | 26.2 | 25.8 | 22.4 | 22.1 | 22.9 |
| Stock-based compensation | 3.05 | 3.66 | 5.81 | 6.33 | 6.13 | 8.28 | 1.67 | 3.99 | 4.34 | 5.02 |
| Deferred income tax | 11.4 | 1.29 | -3.65 | -2.42 | 3.86 | 0.99 | -5.57 | -5.87 | -4.71 | -2.58 |
| Change in receivables | 2.28 | 9.36 | 15.1 | -7.61 | -5.24 | 0.84 | -8.41 | 5.59 | -7.28 | 2.64 |
| Change in inventory | -18 | 14.5 | 8.48 | 2.07 | 10.6 | -15.7 | -21.6 | -16.1 | 2.91 | 21.2 |
| Change in payables | 5.6 | -16.1 | 0.94 | -3.65 | 7.95 | -0.39 | -0.64 | -4.41 | 3.79 | -2.75 |
| Cash from operations | 105 | 101 | 120 | 49.6 | 144 | 172 | 77.2 | 33.9 | 55.5 | 54.3 |
| Capital expenditures | -35.2 | -33.6 | -10.5 | -20.3 | -24.2 | -28.8 | -27.7 | -15.8 | -20.8 | -15.8 |
| Acquisitions | -28.3 | |||||||||
| Purchases of investments | -114 | -283 | -369 | -682 | -365 | -193 | -139 | -109 | ||
| Sales and maturities of investments | 268 | 378 | 603 | 406 | 249 | 146 | 130 | |||
| Cash from investing | -34.9 | -33.6 | -125 | -35.4 | -43.9 | -108 | 13.2 | 40.9 | -13.8 | -9.49 |
| Share buybacks | -14 | -64.9 | -2 | -0.22 | -11.8 | -34.4 | -26.1 | |||
| Dividends paid | -32.8 | -23.9 | -19.2 | -14.3 | -114 | -59.1 | -42.7 | -111 | -11.8 | -10.1 |
| Cash from financing | -52 | -91.2 | -20 | -17.2 | -115 | -63.9 | -46.3 | -125 | -46.9 | -36.4 |
| Net change in cash | 17.9 | -23.6 | -25 | -3.07 | -15.3 | 0.9 | 44.1 | -50 | -5.15 | 8.42 |
| Free cash flow | 69.6 | 67.6 | 109 | 29.3 | 120 | 144 | 49.5 | 18.1 | 34.7 | 38.5 |
| Income taxes paid | 43 | 23.4 | 18.1 | 16 | 30.6 | 49.5 | 28.7 | 26 | 10.6 | 2.8 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 18.7% | Gross profit / revenue. |
| Operating margin | 1.0% | Operating income / revenue. |
| EBITDA margin | 5.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 2.0% | Pre-tax income / revenue. |
| Net margin | 2.1% | Net income / revenue. |
| FCF margin | 8.2% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 11.2% | Cash from operations / revenue. |
| Effective tax rate | -7.7% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 4.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 3.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | 1.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 0.9% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 3.0% | Capital expenditures / revenue. |
| D&A / revenue | 4.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 1.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -2.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -0.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -29.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -23.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -15.8% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -138.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -80.3% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -56.6% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -40.9% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -114.4% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -115.3% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -2.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -11.1% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -17.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 10.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -8.1% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -20.3% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | -10.1% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | -36.5% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | -37.5% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -11.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -3.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 1.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -10.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -11.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -0.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -6.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -3.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -1.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.35x | Current assets / current liabilities. |
| Quick ratio | 2.72x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.64x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 20.4% | Total liabilities / total assets. |
| Interest coverage | 55.7x | Operating income / interest expense. |
| Working capital | $167.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 1.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $286.1M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.58x | Revenue / average total assets. |
| Fixed asset turnover | 7.58x | Revenue / average property, plant and equipment. |
| Inventory turnover | 13.7x | Cost of revenue / average inventory. |
| Days inventory | 27 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 7.49x | Revenue / average receivables. |
| Days sales outstanding | 49 days | 365 x average receivables / revenue. |
| Days payables | 30 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 45 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 388.8% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 26.6% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.75 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $35.47 | Revenue / diluted weighted shares. |
| FCF per share | $2.91 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $3.96 | Cash from operations / diluted weighted shares. |
| Book value per share | $17.81 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $17.58 | Tangible book value / shares outstanding. |
| Cash per share | $7.22 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 51.1% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 13.1% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $684.0M | Share price x shares outstanding. |
| Enterprise value | $566.6M | Market cap + total debt - cash - short-term investments. |
| P/E | 56.2x | Market cap / net income. Only when net income is positive. |
| P/S | 1.19x | Market cap / revenue. |
| P/B | 2.36x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 2.39x | Market cap / tangible book value, when positive. |
| P/FCF | 14.4x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 10.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.98x | Enterprise value / revenue. |
| EV/EBIT | 101x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 19.3x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 12.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 6.9% | Free cash flow / market cap. |
| Earnings yield | 1.8% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.9% | Dividends paid over the period / market cap. |
| Shareholder yield | 0.9% | (Dividends paid + share buybacks) / market cap. |
What was STURM RUGER & CO INC's revenue in fiscal 2025?
STURM RUGER & CO INC reported revenue of $546.1M for fiscal 2025, 1.9% higher than the year before.
Was STURM RUGER & CO INC profitable in fiscal 2025?
No. It reported a net loss of $4.4M.
How much free cash flow did STURM RUGER & CO INC generate in fiscal 2025?
Cash from operations of $54.3M minus capital expenditures of $15.8M left free cash flow of $38.5M.